Cargando…

Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study

INTRODUCTION: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. MATERIALS AND METHODS: It is a retrospective study of 18 ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Deka, Pankaj, Barmon, Debabrata, Shribastava, Sushrata, Kataki, Amal Chandra, Sharma, J. D., Bhattacharyya, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955039/
https://www.ncbi.nlm.nih.gov/pubmed/24672200
http://dx.doi.org/10.4103/0976-7800.127784
_version_ 1782307528672018432
author Deka, Pankaj
Barmon, Debabrata
Shribastava, Sushrata
Kataki, Amal Chandra
Sharma, J. D.
Bhattacharyya, M.
author_facet Deka, Pankaj
Barmon, Debabrata
Shribastava, Sushrata
Kataki, Amal Chandra
Sharma, J. D.
Bhattacharyya, M.
author_sort Deka, Pankaj
collection PubMed
description INTRODUCTION: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. MATERIALS AND METHODS: It is a retrospective study of 18 cases, operated in our institute from 2006 to 2009 and followed up till July, 2012. These patients were divided into two group of node positive and node negative and compared for recurrence and survival. RESULT: Ten patients had lymph node metastasis and eight had no lymph node metastasis. Recurrence rate was 40% and 12.5% in node positive and negative groups, respectively. Adjuvant radiation when given to node negative bulky tumor showed no recurrence compared to one out of two in the non-irradiated group. Survival was only 25% in node positive recurrent cases. CONCLUSION: Lymph node positivity added a great risk for future recurrence. Prophylactic radiation in node negative, bulky tumor is helpful.
format Online
Article
Text
id pubmed-3955039
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39550392014-03-26 Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study Deka, Pankaj Barmon, Debabrata Shribastava, Sushrata Kataki, Amal Chandra Sharma, J. D. Bhattacharyya, M. J Midlife Health Original Article INTRODUCTION: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. MATERIALS AND METHODS: It is a retrospective study of 18 cases, operated in our institute from 2006 to 2009 and followed up till July, 2012. These patients were divided into two group of node positive and node negative and compared for recurrence and survival. RESULT: Ten patients had lymph node metastasis and eight had no lymph node metastasis. Recurrence rate was 40% and 12.5% in node positive and negative groups, respectively. Adjuvant radiation when given to node negative bulky tumor showed no recurrence compared to one out of two in the non-irradiated group. Survival was only 25% in node positive recurrent cases. CONCLUSION: Lymph node positivity added a great risk for future recurrence. Prophylactic radiation in node negative, bulky tumor is helpful. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3955039/ /pubmed/24672200 http://dx.doi.org/10.4103/0976-7800.127784 Text en Copyright: © Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Deka, Pankaj
Barmon, Debabrata
Shribastava, Sushrata
Kataki, Amal Chandra
Sharma, J. D.
Bhattacharyya, M.
Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
title Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
title_full Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
title_fullStr Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
title_full_unstemmed Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
title_short Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
title_sort prognosis of vulval cancer with lymph node status and size of primary lesion: a survival study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955039/
https://www.ncbi.nlm.nih.gov/pubmed/24672200
http://dx.doi.org/10.4103/0976-7800.127784
work_keys_str_mv AT dekapankaj prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy
AT barmondebabrata prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy
AT shribastavasushrata prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy
AT katakiamalchandra prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy
AT sharmajd prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy
AT bhattacharyyam prognosisofvulvalcancerwithlymphnodestatusandsizeofprimarylesionasurvivalstudy